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Autophagy is a specialized cellular pathway involved in maintaining homeostasis 
by degrading long-lived cellular proteins and organelles. Recent studies have dem-
onstrated that autophagy is utilized by immune systems to protect host cells from 
invading pathogens and regulate uncontrolled immune responses. During patho-
gen recognition, induction of autophagy by pattern recognition receptors leads to 
the promotion or inhibition of consequent signaling pathways. Furthermore, au-
tophagy plays a role in the delivery of pathogen signatures in order to promote the 
recognition thereof by pattern recognition receptors. In addition to innate recogni-
tion, autophagy has been shown to facilitate MHC class II presentation of intracel-
lular antigens to activate CD4 T cells. In this review, we describe the roles of au-
tophagy in innate recognition of pathogens and adaptive immunity, such as antigen 
presentation, as well as the clinical relevance of autophagy in the treatment of hu-
man diseases.
Key Words:    Autophagy, pathogen recognition, pattern recognition receptors, anti-
gen presentation
INTRODUCTION
Autophagy is a part of cellular system involved in maintaining homeostasis by de-
grading long-lived cellular constituents.1 It also plays critical roles in providing nu-
trients under starvation and neonatal periods.2,3 There are three types of autophagy: 
macroautophagy, microautophagy, and chaperone-mediated autophagy.4 In chaper-
one-mediated autophagy, signaling motif containing molecules are transported 
with the chaperone HSC70 via LAMP-2A into lysosomes.5-8 In contrast to micro-
autophagy, which is characterized by the removal of constituents via budding of an 
autophagic body at the lysosomal membrane, macroautophagy forms a double-
layered membrane vesicle, called an autophagosome. The autophagosome is 
formed via the elongation of a cup-shaped membrane, and two ubiquitin-like con-
jugation systems are involved in autophagosome propagation.9 At least 30 genes, 
termed autophagy-related genes (Atg), regulate the process of autophagy in 
yeast.10 Once formed, the outer membrane of the autophagosome fuses with a lys-
osome, where cellular contents are degraded within by lysosomal hydrolase and Ji Eun Oh and Heung Kyu Lee
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and imiquimod, induces the formation of autophagosomes, 
characterized by microtubule-associated light chain 3-green 
fluorescent protein (LC3-GFP) puncta formation for the 
elimination of Bacillus Calmette-Guerin.28,29 The induction 
of autophagy is dependent on MyD88. Here, both Atg5 and 
Beclin are required for the induction of autophagy in mac-
rophages after stimulation of TLR7 (Fig. 1A). 
Although most TLR signaling induces autophagosome 
formation, some link autophagy with the enhancement of 
phagocytosis. When zymosan (a particle of fungal cell walls) 
is phagocytosed, LC3, an autophagosome marker, is rapid-
ly recruited to the phagosomal membrane.30 This process 
depends on Atg5 and Atg7. Although translocation of LC3 
to the phagosome is not associated with autophagosome 
formation, it promotes the phagosome to fuse with lyso-
somes in murine macrophages. Interestingly, recruitment of 
LC3 to phagosome depends on TLR2, but not on MyD88 
(Fig. 1A).
In addition to the formation of autophagosomes and mat-
uration of phagosomes by autophagy-related proteins to 
promote TLR-mediated pathogen elimination, autophagy 
supports delivery of viral nucleic acids to lysosomes where 
TLR recognition occurs.31 Within the TLR family, TLR3, 
TLR7, TLR8 and TLR9, located in the endosomal com-
partment, sense endocytosed viral nucleic acids.32 In the 
case of vesicular stomatitis virus (VSV), plasmacytoid den-
dritic cells (pDCs) recognize replication intermediates in 
the cytosol, rather than single-stranded viral RNA via 
TLR7 in the endosome.31 In recognition of cytosolic viral 
PAMP by TLR7, autophagy mediates the transport thereof 
into lysosomes (Fig. 1B). Consistently, pDCs lacking Atg5 
failed to secrete IFN-α and IL-12p40 in response to VSV 
infection, in a previous study. In addition to VSV, a TLR9 
ligand herpes simplex virus (HSV)-1 failed to induce IFN-α 
production in Atg5-deficient pDCs, while the IL-12 re-
sponse remained intact in these cells.31 These data suggest 
that the IFN-α signaling pathway is impaired in the absence 
of Atg5. However, the precise nature of the differential con-
trol of NF-κB versus IFN-α induction pathways in pDCs by 
autophagy remains to be determined.33  
Autophagy in NLR signaling
Although TLRs are the most well-known PRRs, some bac-
terial structures are recognized by intracellular sensors, 
called nucleotide-binding oligomerization domain (NOD)-
like receptors (NLRs).34,35 NLRs are a family of cytoplas-
mic molecules that recognize bacterial cell wall components, 
recycled.11 
Beyond maintaining homeostasis, autophagy is involved 
in multiple biological processes including development, ag-
ing, and degeneration.12 Not surprisingly, aberrant regula-
tion of autophagy induces many diseases such as cancer, 
neurodegenerative disease, and myopathies.13,14 Autophagy 
also has diverse functions in immunity. Various intracellular 
bacteria, viruses, and protozoans are removed from host 
cells by autophagy, and endogenous antigens are processed 
and presented to major histocompatibility complex (MHC) 
class II via autophagy.15-21 In this review, we focus on the 
role of autophagy in innate recognition of pathogens and 
adaptive immune responses.
AUTOPHAGY IN PATHOGEN 
RECOGNITION
Autophagy in TLR signaling
In response to pathogens, various types of pattern recogni-
tion receptors (PRRs) recognize pathogen-associated molec-
ular patterns (PAMPs) and mediate signals to defend to 
pathogens.22 Among PRRs, Toll-like receptors (TLRs) re-
spond to lipopolysaccharides (LPS), lipotechoic acid and 
flagellin on cell surface membranes, as well as to viral/bac-
terial nucleic acids on endosomal membranes.23 TLR4, a re-
ceptor for bacterial LPS, triggers both MyD88- and TIR do-
main-containing adapter-inducing interferon-β (TRIF)-
dependent signaling pathways. The IKK-α-IKK-β-NEMO 
complex and TBK1-IKKi complex mediate the activation of 
the transcription factors NF-κB and interferon regulatory 
factor 3 (IRF3), respectively. In turn, they induce the tran-
scription of proinflammatory cytokines and type I  interfer-
ons (IFNs).24,25 TLR4 signaling via the TRIF-p38 axis, but 
not via MyD88, induces the formation of an autophagosome 
for the elimination of Mycobacteria bacilli.26 Atg6 and Be-
clin-1 are required in this process (Fig. 1A). Interestingly, in 
autophagy-deficient cells, IL-1β and IL-18 production is en-
hanced in response to LPS.27 Macrophages lacking Atg16L1 
induce high-levels of reactive oxygen species (ROS), which 
in turn activates caspase-1, leading to the processing of IL-
1β. However, in macrophages of wild-type mice, the gener-
ation of ROS is inhibited by autophagy-related proteins, and 
in turn, limited amounts of IL-1β are produced (Fig. 1C). 
In addition to TLR4 signaling, other TLRs also activate 
autophagy machinery to eliminate pathogens. TLR7 signal-
ing, induced by two different ligands, single-stranded RNA Autophagy Regulates Innate and Adaptive Immunity
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Fig. 1. Autophagy contributes to innate and adaptive immune responses against pathogens. (A) TLR promotes the induction of autophagy for pathogen elimi-
nation. TLR4 signaling via the TRIF-p38 axis, but not via MyD88, induces the formation of autophagosome and subsequent elimination of Mycobacteria bacil-
li. TLR7 signaling induced by two different ligands, single-stranded RNA and imiquimod, induces the formation of an autophagosome to eliminate Bacillus 
Calmette-Guerin. Atgs, such as Atg5, beclin and PI3K, are required for the formation of autophagosomes via TLR stimulation. In another case, Atg facilitates 
the TLR-dependent elimination of pathogens by promoting phagosome maturation. When zymosan (a particle of fungal cell walls) is phagocytosed, TLR2 in-
duces the recruitment of LC3 to the phagosomal membrane, leading to the maturation of phagosomes and elimination of the fungus. This process depends 
on Atg5 and Atg7. (B) Autophagy supports antiviral responses by promoting viral sensing. In pDCs, autophagy mediates the recognition of the virus infection 
by delivering viral replication intermediates in the cytosol to lysosomes, where TLR recognition occurs. However, in non-pDCs, autophagy negatively regu-
lates antiviral type I IFN responses. The Atg5-Agt12 conjugate directly associates with CARD domains of RIG-I, a cytosolic receptor for viral nucleic acids, 
and IPS-1, suppressing type I IFN production. Consequently in Atg5-deficient MEFs, RLR signaling results in overproduction of type I IFNs and resistance to 
VSV infection. In cases of dsDNA recognition, STING, a multispanning membrane protein, is translocated from the ER to the Golgi apparatus and assembled 
with TBK1, which phosphorylates the transcription factor IRF3, resulting in the production of type I IFN. Atg9a, an essential component of autophagy, is co-
localized with STING in the Golgi apparatus and controls the dynamic translocation of STING and assembly with TBK1. In Atg9a-deficient MEFs, the translo-
cation of STING from the Golgi apparatus to the cytoplasmic punctate structures and assembly with TBK1 are greatly enhanced, which, in turn, induces ab-
errant activation of type I IFN responses. (C) Atg16L1 regulates endotoxin-induced inflammasome activation. In autophagy-deficient cells, IL-1β and IL-18 
production is enhanced in response to LPS. Macrophages lacking Atg16L1 induce high-levels of ROS, which, in turn, activates caspase-1, leading to the 
processing of IL-1β. However, in macrophages of wild-type mice, generation of ROS is inhibited by autophagy-related protein, leading to limited production 
of IL-1β. (D) Autophagy is involved in MHC class II processing and presentation of intracellular antigens to CD4 T cells. Intracellular antigens are engulfed by 
autophagosomes, transported to MHC class II loading compartments (MIIC), and then loaded onto MHC class II molecules for presentation to CD4 T cells. 
TLR, toll-like receptor; Atg, autophagy-related genes; pDCs, plasmacytoid dendritic cells; CARD, caspase recruitment domain; RIG-I, retinoic acid inducible 
gene I; MEFs, mouse embryonic fibroblasts; RLR, RIG-I-like receptor; VSV, vesicular stomatitis virus; STING, stimulator of IFN genes; TBK1, TANK-binding ki-
nase 1; LPS, lipopolysaccharides; ROS, reactive oxygen species; TRIF, TIR domain-containing adapter-inducing interferon-β; IFN, interferon; IPS-1, IFN-β 
promoter stimulator-1; ER, endoplasmic reticulum; IRF, interferon regulatory factor; IL, interleukin; MHC, major histocompatibility complex.
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Moreover, the accumulation of dysfunctional mitochondria 
and ROSs, associated with dysfunctional mitochondria in 
Atg5-deficient cells, potentiated RLR signaling in response 
to viral infections.43 
In cases where double-stranded DNA (dsDNA), derived 
from bacteria or DNA viruses, is detected, the sensing and 
regulation mechanisms thereof are still unclear. Recently, 
studies have shown that dsDNA can induce the production of 
type I IFNs.44,45 In this process, the translocation and assem-
bly of stimulator of IFN genes (STING) and TANK-binding 
kinase 1 (TBK1) are required.46-49 After sensing dsDNA, 
STING, a multispanning membrane protein, is translocated 
from the ER to the Golgi apparatus and assembled with 
TBK1, which phosphorylates the transcription factor IRF3, 
resulting in the production of type I IFN. Atg9a, an essen-
tial component of autophagy, is co-localized with STING in 
the Golgi apparatus and controls the dynamic translocation 
of STING and assembly with TBK1 (Fig. 1B).50 In Atg9a-
deficient MEFs, but not in Atg7- and Atg16L1-deficient 
MEFs, the translocation of STING from the Golgi appara-
tus to the cytoplasmic punctate structures and assembly 
with TBK1 are greatly enhanced, which, in turn, induces 
aberrant activation of type I IFN responses.25 Thus, these 
results demonstrated that Atg9a plays a role in the fine-tun-
ing of innate immune responses. 
AUTOPHAGY IN ANTIGEN 
PRESENTATION
Autophagy has been known to be involved in innate immu-
nity by directly defending against pathogens and by promot-
ing innate recognition of pathogens. Furthermore, autopha-
gy facilitates adaptive immune responses such as antigen 
presentation.51,52 Generally, intracellular cytosolic or nuclear 
antigens are presented by MHC class I molecules to CD8 T 
cells after proteosomal hydrolysis, whereas extracellular an-
tigens are presented by MHC class II molecules to CD4 T 
cells after lysosomal degradation.53,54 Thus, it is somewhat 
expectable that lysosomal degradation of cytoplasmic mole-
cules by autophagy can provide antigens presented by 
MHC class II molecules to activate CD4 T cells (Fig. 1D). 
Indeed, cytosolic and nuclear antigens are composed of 20-
30% of natural ligands of MHC class II molecules.55-57 Re-
cent studies revealed that autophagy is involved in the 
MHC class II processing and presentation of various intra-
cellular antigens to CD4 T cells.17-21 Macrophages, which 
such as peptidoglycans, and initiate signaling cascades to ac-
tivate inflammatory responses.35 NLRs comprise two differ-
ent subsets, NODs and NALP (NACHT-, LRR- and pyrin 
domain-containing proteins). When NLRs recognize bacte-
rial peptidoglycans, they initiate signaling pathways by re-
cruiting protein kinase, which in turn activates NF-κB and 
AP-1, leading to production of cytokines and other mole-
cules of innate immunity.36 Recent studies have shown that 
stimulation of NOD2 by muramyl dipeptide induces activa-
tion of autophagy and clearance of bacteria.37 This effect 
depends on autophagy-related proteins, such as Atg5, Atg7, 
and Atg16L1, as well as receptor interacting serine-threo-
nine kinase-2, a regulator of the NOD2 signaling pathway. 
When NOD2 is stimulated with bacterial components, the 
autophagy protein Atg16L1 is recruited to the plasma mem-
brane at the bacterial entry site.38 This then promotes bacte-
rial trafficking to the autophagosome, maturation of the au-
tophagosome via fusion with a lysosome, and facilitates 
antigen loading to MHC class II molecules to enhance anti-
gen presentation to CD4 T cells. As expected, DCs isolated 
from patients of Crohn’s disease, expressing risk alleles for 
NOD2 or Atg16L1, are not able to induce autophagy path-
ways, and in turn, fail to promote bacterial clearance and 
antigen presentation.37,38
AUTOPHAGY IN CYTOSOLIC PRRS
　　　
Most cell types utilize cytoplasmic receptors, RIG-I-like re-
ceptors (RLRs), to bind to viral RNA. These cytosolic sen-
sors are caspase recruitment domain (CARD)-containing 
proteins, consisted of retinoic acid inducible gene I (RIG-I) 
and melanoma differentiation associated gene 5.39-41 Via 
their CARD domain, RLRs signal with IFN-β promoter 
stimulator-1 (IPS-1) and activate transcription factors, in-
cluding IRF3 and NF-κB, to produce type I IFN and proin-
flammatory cytokines, respectively.36 Although autophagy-
related proteins such as Atg5 mediate transport of viral 
replication intermediates from the cytosol to lysosomes, 
where recognition thereof by TLR7 occurrs,31 autophagy-
related proteins engaged in RLR-mediated viral sensing act 
as negative regulators of anti-viral responses.42 The Atg5-
Agt12 conjugate directly associates with CARD domains 
of RIG-I and IPS-1 to suppress type I IFN production (Fig. 
1B). Consequently in Atg5-deficient mouse embryonic fi-
broblasts (MEFs), RLR signaling resulted in the overpro-
duction of type I IFNs and resistance to VSV infection.42 Autophagy Regulates Innate and Adaptive Immunity
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port, envelope proteins of HIV-1 downregulated autophagy 
pathways by enhancing mammalian target of rapamycin sig-
naling, and consequently autophagy failed to promote MHC 
class II presentation.
AUTOPHAGY IN THERAPY OF 
HUMAN DISEASE
The involvement of autophagy in immunity suggests that 
autophagy may be a target for therapy in various human 
diseases. For example, antigens from pathogens, which in-
duce severe infectious diseases and are targeted by autoph-
agy pathways, can be used to develop vaccines in order to 
enhance MHC class II presentation to CD4 T cells. Also, 
autophagy may be developed to antimicrobial agents based 
on the ideas that enhancing or inhibiting autophagy affects 
host resistance to viral, bacterial and parasitic infection. 
Furthermore, as mutations of autophagy genes such as At-
g16L1 are known to be causal factors of Crohn’s disease,37,38 
modulation of autophagy might ameliorate Crohn’s disease, 
if it can compensate for the functions of Atg16L1. The ba-
sic function of autophagy, degrading damaged or long-lived 
organelles might be a useful target for cancer therapy. How-
ever, controversy remains on whether enhancing or inhibit-
ing autophagy might have beneficial effects on cancer ther-
apy.60-63 In addition, imbalanced control of autophagy has 
demonstrated adverse effects including disturbed negative 
selection with consequent autoimmunity.64,65 Therefore, fur-
ther comprehensive understanding of autophagy will be 
needed for proper modulation thereof without unwanted 
immunologic consequences. 
CONCLUDING REMARKS
Recent studies have demonstrated that autophagy is impor-
tant to immune responses. With its most notable function of 
degrading cytosolic constituents, it has also been shown to 
degrade intracellular microbes. In addition to directly de-
fending against pathogens, autophagy facilitates the sensing 
of pathogens by pattern recognition receptors and modu-
lates consequent signaling pathways in multiple ways. Au-
tophagy promotes the elimination of some bacteria by au-
tophagosome formation, whereas some fungal infections 
are resolved through maturation of phagosomes with the 
assistance of autophagy. Moreover, autophagy promotes the 
are unable to present several epitopes of endogenous C5 
protein (5th component of mouse complement) with MHC 
class II molecules, became able to do so when they were 
treated with low doses of the lysosomotropic agent ammo-
nium chloride.17 Also, MHC class II presentation was abro-
gated when treated with inhibitors of the class III PI3 ki-
nase, which is known to inhibit autophagy induction. The 
presentation of peptides from the tumor antigen mucin 1   
with transfection into DCs by RNA electroporation was in-
hibited to present by treatment of the inhibitor of class III 
PI3 kinase, 3-methyladenine (3-MA) and Wortmannin.18 
Endogenous presentation of cytosolic protein neomycin 
phosphotransferase II (NeoR) on MHC class II was mediat-
ed by autophagy. NeoR was sequestrated into autophago-
somes and delivered to lysosomes. This pathway was 
blocked by 3-MA and Wortmannin.19 Another report indi-
cated that the endogenous nuclear antigen 1 of EBV 
(EBNA1) gains access to the MHC class II presentation 
pathway via autophagy. EBNA1 was accumulated in au-
tophagosomes when lysosomal acidification was inhibited. 
Further, intracellular EBNA1 processing for MHC class II 
presentation was inhibited after siRNA-mediated silencing 
of Atg12, an essential protein involved in autophagosome 
formation.20 A more recent report showed that the targeting 
of a model antigen, influenza matrix protein 1 (MP1), to au-
tophagosomes enhanced MHC class II presentation.21 Via 
fusion of MP1 to LC3, an autophagosome-associated pro-
tein, antigen presentation with MHC class II to MP1-specif-
ic CD4 T cells was enhanced 20-fold, while MHC class I 
presentation to CD8 T cells was not affected. Furthermore, 
siRNA-mediated silencing of Atg12 inhibited MP1-LC3 
transport to the MHC class II compartment. This result im-
plicated that autophagy plays important roles in delivering 
cytosolic antigens to the MHC class II compartment for en-
hanced MHC class II presentation to CD4 T cells.
In recent years, studies have revealed that autophagy pro-
motes MHC class II presentation of extracellular antigens to 
CD4 T cells.58,59 In mice with dendritic cell (DC)-conditional 
deletion in Atg5, CD4 T cell priming after herpes simplex 
virus infection was impaired.58 Atg5-deficient DCs showed 
a pronounced defect in the fusion of phagosomes with lyso-
somes and consequent processing and presentation of 
phagocytosed antigens containing TLR stimuli for MHC 
class II. Similarly, autophagy mediated engulfment of endo-
cytosed extracellular human immunodeficiency virus-1 
(HIV-1) and promoted the processing of peptides for presen-
tation to MHC class II loading compartments.59 In this re-Ji Eun Oh and Heung Kyu Lee
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recognition. Although autophagy usually enhances the sig-
naling pathway after PRRs sense the pathogens, it can also 
negatively regulate the signaling pathway in certain cases. In 
addition to innate recognition, autophagy can be used to fa-
cilitate MHC class II presentation of endogenous intracellu-
lar antigens as well as phagocytosed or endocytosed extra-
cellular antigens to activate CD4 T cells. Since autophagy 
plays multiple roles in immunity, autophagy is a potential 
target for therapies in various human diseases. However, it 
is difficult to determine whether induction or suppression of 
autophagy has beneficial effects, since autophagy is involved 
in multiple pathways of immune regulation. Thus, further 
comprehensive understanding of autophagy will provide a 
more integrated picture of how this system controls innate 
and adaptive immunity.
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